| Pathway ID | hsa04380 |
| Pathway Term | Osteoclast differentiation |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
208 | P31751 | chr19: 40,230,317-40,285,536 |
AKT3 | v-akt murine thymoma viral oncogene homolog 3 |
10000 | Q9Y243 | chr1: 243,488,233-243,851,079 |
BLNK | B-cell linker |
29760 | Q8WV28 | chr10: 96,191,702-96,271,587 |
CREB1 | cAMP responsive element binding protein 1 |
1385 | P16220 | chr2: 207,529,737-207,603,431 |
CSF1R | colony stimulating factor 1 receptor |
1436 | P07333 | chr5: 150,053,291-150,113,372 |
CTSK | cathepsin K |
1513 | P43235 | chr1: 150,796,208-150,808,323 |
CYLD | cylindromatosis (turban tumor syndrome) |
1540 | Q9NQC7 | chr16: 50,742,050-50,801,935 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 | P12314 | chr1: 149,782,671-149,792,518 |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) |
2212 | P12318 | chr1: 161,505,430-161,524,013 |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 | P31994 | chr1: 161,663,147-161,678,654 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
2215 | O75015 | chr1: 161,623,196-161,631,963 |
FOS | FBJ murine osteosarcoma viral oncogene homolog |
2353 | P01100 | chr14: 75,278,774-75,282,230 |
FOSB | FBJ murine osteosarcoma viral oncogene homolog B |
2354 | P53539 | chr19: 45,467,995-45,475,179 |
FOSL1 | FOS-like antigen 1 |
8061 | P15407 | chr11: 65,892,049-65,900,573 |
FOSL2 | FOS-like antigen 2 |
2355 | P15408 | chr2: 28,392,448-28,417,312 |
FYN | FYN proto-oncogene, Src family tyrosine kinase |
2534 | P06241 | chr6: 111,660,332-111,873,452 |
GRB2 | growth factor receptor bound protein 2 |
2885 | P62993 | chr17: 75,318,076-75,405,709 |
IFNAR1 | interferon (alpha, beta and omega) receptor 1 |
3454 | P17181 | chr21: 33,324,477-33,359,862 |
IFNAR2 | interferon (alpha, beta and omega) receptor 2 |
3455 | P48551 | chr21: 33,229,901-33,265,675 |
IFNGR1 | interferon gamma receptor 1 |
3459 | P15260 | chr6: 137,197,484-137,219,449 |
IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) |
3460 | P38484 | chr21: 33,402,896-33,479,348 |
IL1A | interleukin 1 alpha |
3552 | P01583 | chr2: 112,773,915-112,784,590 |
IL1B | interleukin 1 beta |
3553 | P01584 | chr2: 112,829,751-112,836,903 |
IL1R1 | interleukin 1 receptor, type I |
3554 | P14778 | chr2: 102,064,544-102,179,874 |
IRF9 | interferon regulatory factor 9 |
10379 | Q00978 | chr14: 24,161,053-24,166,565 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
JAK1 | Janus kinase 1 |
3716 | P23458 | chr1: 64,833,229-64,966,504 |
JUN | jun proto-oncogene |
3725 | P05412 | chr1: 58,780,788-58,784,327 |
JUNB | jun B proto-oncogene |
3726 | P17275 | chr19: 12,791,496-12,793,315 |
JUND | jun D proto-oncogene |
3727 | P17535 | chr19: 18,279,760-18,281,622 |
LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 | Q8NHL6 | chr19: 54,617,158-54,637,528 |
MAP2K1 | mitogen-activated protein kinase kinase 1 |
5604 | Q02750 | chr15: 66,386,817-66,492,312 |
MAP2K6 | mitogen-activated protein kinase kinase 6 |
5608 | P52564 | chr17: 69,414,698-69,543,331 |
MAP2K7 | mitogen-activated protein kinase kinase 7 |
5609 | O14733 | chr19: 7,903,843-7,914,478 |
MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
6885 | O43318 | chr6: 90,513,573-90,587,045 |
MAPK1 | mitogen-activated protein kinase 1 |
5594 | P28482 | chr22: 21,754,500-21,867,680 |
MAPK13 | mitogen-activated protein kinase 13 |
5603 | O15264 | chr6: 36,127,809-36,144,524 |
MAPK14 | mitogen-activated protein kinase 14 |
1432 | Q16539 | chr6: 36,027,677-36,111,236 |
MAPK3 | mitogen-activated protein kinase 3 |
5595 | P27361 | chr16: 30,114,105-30,123,506 |
MAPK8 | mitogen-activated protein kinase 8 |
5599 | P45983 | chr10: 48,306,639-48,439,360 |
MAPK9 | mitogen-activated protein kinase 9 |
5601 | P45984 | chr5: 180,233,143-180,292,099 |
MITF | microphthalmia-associated transcription factor |
4286 | O75030 | chr3: 69,739,435-69,968,337 |
NCF2 | neutrophil cytosolic factor 2 |
4688 | P19878 | chr1: 183,555,563-183,590,876 |
NCF4 | neutrophil cytosolic factor 4 |
4689 | Q15080 | chr22: 36,860,988-36,878,015 |
NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
4772 | O95644 | chr18: 79,395,856-79,529,325 |
NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 | Q13469 | chr20: 51,386,957-51,562,831 |
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 | P19838 | chr4: 102,501,329-102,617,302 |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 | P42336 | chr3: 179,148,114-179,240,093 |
PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 | P42338 | chr3: 138,652,699-138,834,938 |
PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 | O00329 | chr1: 9,651,732-9,729,114 |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
5295 | P27986 | chr5: 68,215,720-68,301,821 |
PLCG2 | phospholipase C gamma 2 |
5336 | P16885 | chr16: 81,739,097-81,962,693 |
PPARG | peroxisome proliferator-activated receptor gamma |
5468 | P37231 | chr3: 12,287,368-12,434,356 |
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 | Q08209 | chr4: 101,023,409-101,348,278 |
PPP3R2 | protein phosphatase 3 regulatory subunit B, beta |
5535 | Q96LZ3 | chr9: 101,591,615-101,595,021 |
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 | P63000 | chr7: 6,374,523-6,403,977 |
RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 | Q04206 | chr11: 65,653,596-65,663,094 |
RELB | v-rel avian reticuloendotheliosis viral oncogene homolog B |
5971 | Q01201 | chr19: 45,001,430-45,038,198 |
SIRPA | signal-regulatory protein alpha |
140885 | P78324 | chr20: 1,894,167-1,940,592 |
SOCS1 | suppressor of cytokine signaling 1 |
8651 | O15524 | chr16: 11,254,405-11,256,179 |
SOCS3 | suppressor of cytokine signaling 3 |
9021 | O14543 | chr17: 78,356,778-78,360,077 |
SQSTM1 | sequestosome 1 |
8878 | Q13501 | chr5: 179,806,398-179,838,078 |
STAT2 | signal transducer and activator of transcription 2 |
6773 | P52630 | chr12: 56,341,597-56,360,155 |
SYK | spleen tyrosine kinase |
6850 | P43405 | chr9: 90,801,787-90,898,549 |
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
10454 | Q15750 | chr22: 39,399,741-39,437,060 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
TGFBR1 | transforming growth factor beta receptor I |
7046 | P36897 | chr9: 99,104,038-99,154,192 |
TGFBR2 | transforming growth factor beta receptor II |
7048 | P37173 | chr3: 30,606,502-30,694,142 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF11A | tumor necrosis factor receptor superfamily member 11a |
8792 | Q9Y6Q6 | chr18: 62,325,287-62,391,292 |
TNFRSF11B | tumor necrosis factor receptor superfamily member 11b |
4982 | O00300 | chr8: 118,923,557-118,952,200 |
TNFSF11 | tumor necrosis factor superfamily member 11 |
8600 | O14788 | chr13: 42,562,736-42,608,013 |
TYROBP | TYRO protein tyrosine kinase binding protein |
7305 | O43914 | chr19: 35,904,401-35,908,295 |